PEG Ratio: 0.72
Is the PEG ratio high or low?
The PEG ratio of 0.72 is 46% below its 5-year average of 1.33, near the low end of its 5-year range (0.62–2.44).
47.25% below its 12-month average of 1.36.
RMD PEG Ratio Chart
Reported annual fiscal-period values; no daily interpolation.
RMD Average PEG Ratio Chart
RMD Current vs Average PEG Ratio Chart
RMD PEG Ratio Metrics
PEG RATIO
0.72
PEG RATIO AVG TTM
1.36
PEG RATIO AVG 3Y
1.45
PEG RATIO AVG 5Y
1.33
PEG RATIO AVG 10Y
2.29
PEG RATIO AVG 15Y
1.24
PEG RATIO AVG 20Y
1.13
CURRENT VS TTM AVG
-47.25%
CURRENT VS 3Y AVG
-50.26%
CURRENT VS 5Y AVG
-45.78%
CURRENT VS 10Y AVG
-68.56%
CURRENT VS 15Y AVG
-41.85%
CURRENT VS 20Y AVG
-36.52%
RMD Competitors' PEG Ratio
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ResMed Inc. (RMD) | $28.81B | 0.72 | 1.36 | 1.45 | 1.33 |
| Biogen Inc. (BIIB)vs › | $29.82B | N/A | 0.34 | 0.24 | 0.23 |
| IQVIA Holdings Inc. (IQV)vs › | $31.12B | 6.34 | 8.50 | 5.12 | 3.87 |
| DexCom, Inc. (DXCM)vs › | $26.49B | 0.67 | 19.51 | 10.66 | 8.56 |
| Veeva Systems Inc. (VEEV)vs › | $25.68B | 1.42 | 1.47 | 5.65 | 5.88 |
| Medline Inc. (MDLN)vs › | $31.94B | N/A | 0.07 | 0.07 | 0.07 |
| Centene Corp. (CNC)vs › | $31.98B | N/A | 0.18 | 0.16 | 0.16 |
| Mettler-Toledo International Inc. (MTD)vs › | $25.13B | 8.96 | 5.67 | 4.53 | 3.90 |
| Zoetis Inc. (ZTS)vs › | $32.62B | 2.04 | 2.96 | 3.83 | 3.78 |
| Waters Corporation (WAT)vs › | $24.57B | 75.61 | 75.61 | 40.77 | 27.51 |
Growth-Adjusted Valuation
PEG Ratio
0.72
P/E Ratio
19.2
PEG Ratio Formula & Definition
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
PEG Ratio FAQ
- What is the PEG ratio for ResMed Inc. (RMD)?
- The PEG ratio for RMD stock is 0.72.
- Is ResMed Inc.'s PEG ratio high or low?
- The PEG ratio of 0.72 is 46% below its 5-year average of 1.33, near the low end of its 5-year range (0.62–2.44).
- What is the TTM average PEG ratio for ResMed Inc. (RMD)?
- The TTM average PEG ratio for RMD stock is 1.36.
- What is the 3Y average PEG ratio for ResMed Inc. (RMD)?
- The 3Y average PEG ratio for RMD stock is 1.45.
- What is the 5Y average PEG ratio for ResMed Inc. (RMD)?
- The 5Y average PEG ratio for RMD stock is 1.33.
- What is the 10Y average PEG ratio for ResMed Inc. (RMD)?
- The 10Y average PEG ratio for RMD stock is 2.29.
- What is the 15Y average PEG ratio for ResMed Inc. (RMD)?
- The 15Y average PEG ratio for RMD stock is 1.24.
- What is the 20Y average PEG ratio for ResMed Inc. (RMD)?
- The 20Y average PEG ratio for RMD stock is 1.13.
RMD PEG Ratio History
| DATE | PEG RATIO |
|---|---|
| 2025-06-30 | 0.72 |
| 2024-06-30 | 2.01 |
| 2023-06-30 | 2.44 |
| 2022-06-30 | 0.62 |
| 2020-06-30 | 0.85 |
| 2019-06-30 | 1.56 |
| 2015-06-30 | 7.83 |
| 2014-06-30 | 1.54 |
| 2013-06-30 | 0.91 |
| 2012-06-30 | 1.02 |
| 2011-06-30 | 1.14 |
| 2010-06-30 | 0.81 |
| 2009-06-30 | 0.60 |
| 2008-06-30 | 0.37 |
| 2006-06-30 | 1.29 |
| 2005-06-30 | 3.77 |
| 2004-06-30 | 1.30 |
| 2003-06-30 | 1.35 |
| 2002-06-30 | 0.11 |
| 2000-06-30 | 0.99 |
| 1999-06-30 | 0.56 |
| 1998-06-30 | 0.72 |
| 1997-06-30 | 0.40 |
Related Metrics
About ResMed Inc.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Michael J. Farrell